Schedule 13G ownership disclosure

Sunesis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 867328700

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,162,473
Percent of class
5.5700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-17-000012
Form type
SC 13G/A
Filer
Palo Alto Investors LP
CIK
CIK 1306923
Filed
Jan 13, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub